NCT05091060View on ClinicalTrials.gov

Effect of the Erchonia® HLS™ for the Relief of Tinnitus Symptoms

NATerminatedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

June 10, 2021

Primary Completion Date

March 14, 2022

Study Completion Date

March 14, 2022

Conditions
Tinnitus
Interventions
DEVICE

Erchonia HLS

56 procedure administrations with the Erchonia® HLS™ administered by the subject at home: daily procedure administrations for 8 weeks.

Trial Locations (1)

94598

Kathy Amos, Walnut Creek

Sponsors
All Listed Sponsors
lead

Erchonia Corporation

INDUSTRY